Ardelyx, Inc. (ARDX) Financials
ARDX Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 297.6 million | 130.8 million |
2023-09-30 | 289.4 million | 98.2 million |
2023-06-30 | 211.2 million | 88.0 million |
2023-03-31 | 217.0 million | 91.6 million |
ARDX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -8.8 million | 3.9 million |
2023-09-30 | -21.7 million | 3.5 million |
2023-06-30 | -14.8 million | 3.2 million |
2023-03-31 | -44.8 million | 2.9 million |
ARDX Net Income
No data available :(
ARDX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 184.3 million | - | 6.2 million |
2023-09-30 | 165.1 million | - | 7.2 million |
2023-06-30 | 127.6 million | - | 7.9 million |
2023-03-31 | 130.4 million | - | 8.8 million |
ARDX Shares Outstanding
ARDX Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 43000 | 9.5 million | 47.7 million | - |
2023-09-30 | 194000 | 8.6 million | 32.7 million | - |
2023-06-30 | 93000 | 8.3 million | 27.2 million | - |
2023-03-31 | 14000 | 9.1 million | 26.8 million | - |
ARDX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 34.4 million | 5.1 million |
2023-09-30 | 56.4 million | 7.0 million |
2023-06-30 | 22.3 million | 3.5 million |
2023-03-31 | 11.4 million | 1.5 million |
ARDX
Price: $8.72
52 week price:
Earnings Per Share: -0.30 USD
P/E Ratio: -148.17
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 8.1 million
Ebitda: -20.5 millionMarket Capitalization: 1.6 billion